GleamWall
中文EN

NUMD Nu-Med Plus, Inc.

Gold and Silver Ores · OTC · SEC CIK 1543637 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY17.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-650.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets3,529.1%
Debt / equity—
Current ratio0.03x
Interest coverage-6.77x

Cash quality & payout

Operating cash flow / net income0.85x
Accruals ratio-94.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-302024Q22024-06-302024Q12024-03-31
Income statement
Revenue$0$0$0$0————
SG&A expense$8,073$4,832$5,469$5,705$6,037$9,467—$5,984
Operating income-$22,556-$13,151-$10,419-$18,700-$9,294-$17,417—-$20,579
Interest expense$2,774$2,727$1,246$1,233$1,261$1,260—$1,247
Pretax income$19,670—-$11,665—-$10,555-$18,677——
Income tax$0$0$0—————
Net income$19,670-$15,878-$11,665-$19,933-$10,555-$18,677-$17,287-$21,826
EBITDA-$22,556-$13,151-$10,419-$18,700————
EPS (basic)0.000.000.000.00—0.00—0.00
EPS (diluted)0.00—0.00——0.00—0.00
Weighted avg. shares (diluted)83.55M83.55M83.55M83.55M—81.35M—83.55M
Balance sheet
Cash & equivalents$5,409$4,284$863$2,373$2,373$4,041—$6,356
Current assets$12,909$7,184——$9,373$6,841—$9,016
PP&E, net$0$0——————
Total assets$12,909$7,184——$9,373$6,841—$9,016
Current liabilities$280,395$294,340——$224,469$211,382—$177,593
Long-term debt$0$0——————
Total debt$0$0——————
Total liabilities$280,395$294,340——$224,469$211,382—$177,593
Shareholders' equity-$267,486-$287,156-$246,694-$235,029-$215,096-$204,541-$185,864-$168,577
Net debt-$5,409-$4,284——————
Shares outstanding83.55M83.55M——83.55M83.55M—83.55M
Cash flow statement
Operating cash flow$1,125-$6,377-$1,510$0-$1,668——-$450
Investing cash flow$0$0$0$0————
Financing cash flow$0$10,000$0$0————
Depreciation & amortization$0$0$0$0————

Free plan shows the latest 8 periods; Pro shows all 56 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.